This filing is part of the company’s quarterly result. Read the full results article, with every figure explained →
Q2 FY27 consolidated (Rs lakh): revenue 3,942.57, PAT 110.07; Q2 FY26 revenue 3,864.75, PAT 91.37
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved in line with Nifty Microcap 250 and 1.5 pts more than its Trading - Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
In the consolidated quarter ended 30 September 2026, revenue from operations was Rs 3,942.57 lakh versus Rs 3,864.75 lakh in the same quarter a year earlier; profit after tax was Rs 110.07 lakh versus Rs 91.37 lakh. EBITDA margin fell to 1.2% from 3.2%. Consolidated half-year to September 2026: revenue was Rs 5,660.97 lakh, profit after tax Rs 214.25 lakh and operating cash flow was negative Rs 235.90 lakh. The Board approved the results.
Profit rose, but a lower operating margin and negative half-year operating cash flow may weigh on the stock; low debt offers some support.
| Q2 FY27 | Q2 FY26 | Change | |
|---|---|---|---|
| Revenue | ₹39.43 Cr | ₹38.65 Cr | +2.0% |
| Operating profit | ₹0.11 Cr | ₹0.88 Cr | −87.3% |
| Profit after tax | ₹1.10 Cr | ₹0.91 Cr | +20.5% |
| EBITDA margin | 1.2% | 3.2% | −2.0 pp |
From the company's XBRL filing, not from the text above. Operating profit = profit before tax − exceptional items − other income. EBITDA = profit before tax + finance costs + depreciation − other income.